Dihydroergotamine Alternatives Compared
Dihydroergotamine | Ubrelvy | Atogepant |
|
---|
Dihydroergotamine | Ubrelvy (ubrogepant) | Atogepant |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Cluster Headaches, Headache, Migraine. dihydroergotamine may also be used for purposes not listed in this medication guide. |
Prescription only
Ubrelvy is a prescription medicine that may be used to treat acute migraine attacks in adults and works by blocking the effects of a protein, called CGRP that is thought to play a role in migraine... View more |
Prescription only
Prescribed for Chronic Migraine, Migraine Prevention, Migraine, Headache. atogepant may also be used for purposes not listed in this medication guide. |
Related suggestions Migraine
|
|||||||||||||||
More about Dihydroergotamine | More about Ubrelvy (ubrogepant) | More about Atogepant | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Dihydroergotamine has an average rating of 7.1 out of 10 from a total of 45 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 23% reported a negative effect. |
Ubrelvy has an average rating of 6.2 out of 10 from a total of 244 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 38% reported a negative effect. |
Atogepant has an average rating of 7.9 out of 10 from a total of 145 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: dihydroergotamine side effects in more detail. |
See also: Ubrelvy side effects in more detail. |
See also: atogepant side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all dihydroergotamine prices |
View all Ubrelvy prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
Brand Names | ||||||||||||||||||
D.H.E. 45, Migranal, Trudhesa |
N/A |
Qulipta | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
15 hours |
7 hours |
11 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 342 drugs are known to interact with dihydroergotamine:
|
A total of 223 drugs are known to interact with Ubrelvy:
|
A total of 182 drugs are known to interact with atogepant:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.